Chan S - Search Results

1

Targeting XRCC1 deficiency in breast cancer for personalized therapy.

Sultana R, Abdel-Fatah T, Abbotts R, Hawkes C, Albarakati N, Seedhouse C, Ball G, Chan S, Rakha EA, Ellis IO, Madhusudan S. Sultana R, et al. Among authors: chan s. Cancer Res. 2013 Mar 1;73(5):1621-34. doi: 10.1158/0008-5472.CAN-12-2929. Epub 2012 Dec 19. Cancer Res. 2013. PMID: 23253910

2

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.

Willsher PC, Pinder SE, Gee JM, Ellis IO, Chan SY, Nicholson RI, Blamey RW, Robertson JF. Willsher PC, et al. Among authors: chan sy. Anticancer Res. 1998 Sep-Oct;18(5B):3695-8. Anticancer Res. 1998. PMID: 9854479

3

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

Panigrahi AR, Pinder SE, Chan SY, Paish EC, Robertson JF, Ellis IO. Panigrahi AR, et al. Among authors: chan sy. J Pathol. 2004 Sep;204(1):93-100. doi: 10.1002/path.1611. J Pathol. 2004. PMID: 15307142

4

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF. Mathew J, et al. Among authors: chan sy. Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27. Eur J Surg Oncol. 2007. PMID: 17391905 Clinical Trial.

5

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.

Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI, Ellis IO. Aleskandarany MA, et al. Among authors: chan s. Int J Cancer. 2010 Apr 1;126(7):1761-9. doi: 10.1002/ijc.24860. Int J Cancer. 2010. PMID: 19711345

6

Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy.

Shehata M, Mukherjee A, Deen S, Al-Attar A, Durrant LG, Chan S. Shehata M, et al. Among authors: chan s. Br J Cancer. 2009 Oct 20;101(8):1321-8. doi: 10.1038/sj.bjc.6605315. Epub 2009 Sep 15. Br J Cancer. 2009. PMID: 19755991 Free PMC article.

7

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.

Al-Attar A, Gossage L, Fareed KR, Shehata M, Mohammed M, Zaitoun AM, Soomro I, Lobo DN, Abbotts R, Chan S, Madhusudan S. Al-Attar A, et al. Among authors: chan s. Br J Cancer. 2010 Feb 16;102(4):704-9. doi: 10.1038/sj.bjc.6605541. Epub 2010 Jan 19. Br J Cancer. 2010. PMID: 20087352 Free PMC article.

8

Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.

Mukherjee A, Shehata M, Moseley P, Rakha E, Ellis I, Chan S. Mukherjee A, et al. Among authors: chan s. Br J Cancer. 2010 Dec 7;103(12):1794-800. doi: 10.1038/sj.bjc.6605960. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063406 Free PMC article.

9

Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy.

Storr SJ, Woolston CM, Barros FF, Green AR, Shehata M, Chan SY, Ellis IO, Martin SG. Storr SJ, et al. Int J Cancer. 2011 Oct 1;129(7):1773-80. doi: 10.1002/ijc.25832. Epub 2011 Mar 8. Int J Cancer. 2011. PMID: 21140455

10

Metastatic triple-negative breast cancer.

Rakha EA, Chan S. Rakha EA, et al. Among authors: chan s. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):587-600. doi: 10.1016/j.clon.2011.03.013. Epub 2011 Apr 23. Clin Oncol (R Coll Radiol). 2011. PMID: 21524569 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,862 results

Search Page

Filters